rs700233

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001737.5(C9):​c.13C>T​(p.Arg5Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.383 in 1,600,716 control chromosomes in the GnomAD database, including 121,576 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R5Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.35 ( 9967 hom., cov: 32)
Exomes 𝑓: 0.39 ( 111609 hom. )

Consequence

C9
NM_001737.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -2.28

Publications

40 publications found
Variant links:
Genes affected
C9 (HGNC:1358): (complement C9) This gene encodes the final component of the complement system. It participates in the formation of the Membrane Attack Complex (MAC). The MAC assembles on bacterial membranes to form a pore, permitting disruption of bacterial membrane organization. Mutations in this gene cause component C9 deficiency. [provided by RefSeq, Feb 2009]
C9 Gene-Disease associations (from GenCC):
  • complement component 9 deficiency
    Inheritance: Unknown, AR Classification: STRONG, MODERATE Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.7780066E-4).
BP6
Variant 5-39364452-G-A is Benign according to our data. Variant chr5-39364452-G-A is described in ClinVar as Benign. ClinVar VariationId is 402466.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.407 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C9NM_001737.5 linkc.13C>T p.Arg5Trp missense_variant Exon 1 of 11 ENST00000263408.5 NP_001728.1 P02748

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C9ENST00000263408.5 linkc.13C>T p.Arg5Trp missense_variant Exon 1 of 11 1 NM_001737.5 ENSP00000263408.4 P02748

Frequencies

GnomAD3 genomes
AF:
0.353
AC:
53587
AN:
151946
Hom.:
9971
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.258
Gnomad AMI
AF:
0.345
Gnomad AMR
AF:
0.392
Gnomad ASJ
AF:
0.461
Gnomad EAS
AF:
0.0706
Gnomad SAS
AF:
0.358
Gnomad FIN
AF:
0.373
Gnomad MID
AF:
0.506
Gnomad NFE
AF:
0.411
Gnomad OTH
AF:
0.417
GnomAD2 exomes
AF:
0.360
AC:
90006
AN:
249768
AF XY:
0.368
show subpopulations
Gnomad AFR exome
AF:
0.256
Gnomad AMR exome
AF:
0.347
Gnomad ASJ exome
AF:
0.468
Gnomad EAS exome
AF:
0.0552
Gnomad FIN exome
AF:
0.370
Gnomad NFE exome
AF:
0.414
Gnomad OTH exome
AF:
0.411
GnomAD4 exome
AF:
0.386
AC:
559842
AN:
1448652
Hom.:
111609
Cov.:
28
AF XY:
0.388
AC XY:
279669
AN XY:
721376
show subpopulations
African (AFR)
AF:
0.253
AC:
8434
AN:
33284
American (AMR)
AF:
0.352
AC:
15746
AN:
44670
Ashkenazi Jewish (ASJ)
AF:
0.462
AC:
12024
AN:
26030
East Asian (EAS)
AF:
0.101
AC:
3996
AN:
39662
South Asian (SAS)
AF:
0.357
AC:
30706
AN:
85918
European-Finnish (FIN)
AF:
0.372
AC:
19561
AN:
52634
Middle Eastern (MID)
AF:
0.501
AC:
2882
AN:
5754
European-Non Finnish (NFE)
AF:
0.403
AC:
443608
AN:
1100738
Other (OTH)
AF:
0.382
AC:
22885
AN:
59962
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
14554
29108
43663
58217
72771
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13312
26624
39936
53248
66560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.352
AC:
53598
AN:
152064
Hom.:
9967
Cov.:
32
AF XY:
0.353
AC XY:
26204
AN XY:
74324
show subpopulations
African (AFR)
AF:
0.258
AC:
10677
AN:
41458
American (AMR)
AF:
0.391
AC:
5979
AN:
15278
Ashkenazi Jewish (ASJ)
AF:
0.461
AC:
1600
AN:
3468
East Asian (EAS)
AF:
0.0708
AC:
366
AN:
5172
South Asian (SAS)
AF:
0.359
AC:
1731
AN:
4826
European-Finnish (FIN)
AF:
0.373
AC:
3934
AN:
10554
Middle Eastern (MID)
AF:
0.500
AC:
146
AN:
292
European-Non Finnish (NFE)
AF:
0.412
AC:
27981
AN:
67996
Other (OTH)
AF:
0.412
AC:
869
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.509
Heterozygous variant carriers
0
1768
3537
5305
7074
8842
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
522
1044
1566
2088
2610
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.385
Hom.:
33756
Bravo
AF:
0.348
TwinsUK
AF:
0.393
AC:
1459
ALSPAC
AF:
0.397
AC:
1529
ESP6500AA
AF:
0.254
AC:
1121
ESP6500EA
AF:
0.414
AC:
3563
ExAC
AF:
0.361
AC:
43802
Asia WGS
AF:
0.234
AC:
819
AN:
3478
EpiCase
AF:
0.430
EpiControl
AF:
0.435

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.82
T
BayesDel_noAF
Benign
-0.81
CADD
Benign
0.019
DANN
Benign
0.51
DEOGEN2
Benign
0.016
T
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.9
FATHMM_MKL
Benign
0.021
N
LIST_S2
Benign
0.50
T
MetaRNN
Benign
0.00018
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.34
N
PhyloP100
-2.3
PrimateAI
Benign
0.19
T
PROVEAN
Benign
-0.85
N
REVEL
Benign
0.049
Sift
Benign
0.21
T
Sift4G
Benign
0.19
T
Polyphen
0.0
B
Vest4
0.021
MPC
0.034
ClinPred
0.012
T
GERP RS
-8.7
PromoterAI
-0.036
Neutral
Varity_R
0.031
gMVP
0.28
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs700233; hg19: chr5-39364554; COSMIC: COSV54676608; API